Hyphens Pharma International Ltd. · SGX:1J5
Hyphens Pharma International — Shareholder Meeting (April 2019)
30 slides from Hyphens Pharma International's shareholder meeting presentation, Apr 26, 2019
Slide 1: AGM Announcement Details
REPL::ANNUAL GENERAL MEETING::VOLUNTARY Issuer & Securities Issuer/ Manager HYPHENS PHARMA INTERNATIONAL LIMITED Security HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5 Announcement Details Announcement Title Annual General Meeting Date &Time of Broadcast 26-Apr-2019 18:30:04 Status Replacement An
Slide 2: Meeting Venue and Attachments
Place Venue(s) Venue details Meeting Venue 16 Tai Seng Street #04-01 Singapore 534138 Attachments Hyphens-Notice%20of%20AGM.pdf Hyphens%20AGM%20FY2018%20Presentation.pdf HPIL%20-%20Annt%20-%20Results%20of%20AGM_260419.pdf Total size =3383K MB Related Announcements Related Announcements 10/04/2019 18
Slide 3: Results of the Annual General Meeting
HYPHENS PHARMA INTERNATIONAL LIMITED (Company Registration No. 201735688C) (Incorporated in the Republic of Singapore) 1. RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 APRIL 2019 2. RE-APPOINTMENT OF DIRECTORS 1. RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 APRIL 2019 The Board of Directors o
Slide 4: Poll Results: Resolutions 2-6
HYPHENS PHARMA INTERNATIONAL LIMITED (Company Registration No. 201735688C) (Incorporated in the Republic of Singapore) Resolution Number Total No. of For Against and Details Shares Represented Number of Percentage Number of Percentage by Votes For Shares (%) Shares (%) and Against Ordinary Resolutio
Slide 5: Poll Results: Resolutions 7-10
HYPHENS PHARMA INTERNATIONAL LIMITED (Company Registration No. 201735688C) (Incorporated in the Republic of Singapore) Resolution Number Total No. of For Against and Details Shares Represented Number of Percentage Number of Percentage by Votes For Shares (%) Shares (%) and Against Ordinary Resolutio
Slide 6: Poll Results and Abstentions
HYPHENS PHARMA INTERNATIONAL LIMITED (Company Registration No. 201735688C) (Incorporated in the Republic of Singapore) Resolution Number Total No. of For Against and Details Shares Represented Number of Percentage Number of Percentage by Votes For Shares (%) Shares (%) and Against Ordinary Resolutio
Slide 7: Scrutineer and Re-appointment of Directors
HYPHENS PHARMA INTERNATIONAL LIMITED (Company Registration No. 201735688C) (Incorporated in the Republic of Singapore) (c) Scrutineer Drewcorp Services Pte Ltd was appointed as the Company’s scrutineer for the AGM. 2. RE-APPOINTMENT OF DIRECTORS – STATEMENT PURSUANT TO RULE 704(7) OF THE RULES OF CA
Slide 8: Hyphens Pharma International Limited Annual General Meeting
Hyphens Pharma International Limited Annual General Meeting 26 April 2019 HYPHENS PHARMA INTL LTD (SGX: 1J5)
Slide 9: Disclaimer
DISCLAIMER This presentation has been prepared by Hyphens Pharma International Limited (the "Company" and, together with its subsidiaries, the "Group"). This content in this presentation is being furnished to you on a confidential basis and solely for your information and neither this presentation n
Slide 10: Company Snapshot
COMPANY SNAPSHOT ON LISTED ON 18 MAY THE 2018 SGX-CATALIST 3 CORE 2018 REVENUE 5 COUNTRIES BUSINESSES S$121 MILLION 450 PERSONNEL 14 of our products are sold every minute!
Slide 11: Our Business Segments
OUR BUSINESS SEGMENTS Specialty Pharma Principals Proprietary Brands Medical Hypermart and Digital
Slide 12: Specialty Pharma Principals
SPECIALTY PHARMA PRINCIPALS What We Do 1. Handle specialised products, under exclusive agreements with our principals from Europe and the US. 2. Register and hold product licenses with local authorities. 3. Promote products through medical representatives to specialists and GPs.
Slide 13: Our Regional Footprint
OUR REGIONAL FOOTPRINT Our People 1882 23 29 148 622 Direct presence 1. As at 31 Dec 2018 2. Based on representative offices and distributors
Slide 14: Contrast Media Products
CONTRAST MEDIA PRODUCTS GUERBET – XENETIX® DOTAREM® LIPIODOL® Our products are used for: • X-Rays • CT Scans • MRI Participation in Scientific Congresses 25 years of working relationship 2018 Revenue Contribution: 13.7% Booth Presence Symposiums
Slide 15: ENT (Ear, Nose, Throat) & Allergy
ENT (EAR, NOSE, THROAT) & ALLERGY
Slide 16: Other Specialty Pharma Products
OTHER SPECIALTY PHARMA PRODUCTS Interventional Cardiology Gastroenterology (Biosensors Coronary Stents) Obstetrics & Gynaecology Otorhinolaryngology Rheumatology Ophthalmology Neuroscience & Psychiatry Family Medicine
Slide 17: Proprietary Brands
PROPRIETARY BRANDS What We Do 1. Direct ownership of the products under various brand names and market them to the world. 2. Constantly engaged in product research & development. 3. Contract manufacture these products, bearing our trademarks.
Slide 18: Brands We Own
BRANDS WE OWN Ccé€an am Ceradan’ Quality You Can Trust DERMA FORMULA
Slide 19: Atopic Dermatitis Range
ATOPIC DERMATITIS RANGE Gentle Non-Soap Wash Maintenance Therapy * Triple Protective Action Specially-Formulated Against Diaper Rash Mosquito Repellent For AD Menthol Gel to Calm & Soothe Itchy Skin Ceramide-Dominant Therapeutic Moisturiser *IQVIA 2018 Q3 Survey on Top-of-Mind Awareness on 31 Privat
Slide 20: TDF Derma Formula
TDF® DERMA FORMULA HOME CARE OILY & ACNE DRY & SENSITIVE HYPER- PIGMENTATION AGE DEFENSE CHEMICAL PEEL
Slide 21: 1 Omega-3: A Well-Regarded Brand by Consumers
A WELL-REGARDED BRAND BY CONSUMERS Brand that I can trust# Good value for money# WINNER WINNER Guardian Health & Watsons Beauty Awards HWB Award since 2008 since 2007 1OMEGA-3 * WINNER WINNER SINGAPORE’S NO. Unity Popular Superbrands Choice Award Status since 2008 since 2004 # 2018 Nielsen Surve
Slide 22: Nutritional Supplements
NUTRITIONAL SUPPLEMENTS Clinical Series is a professional range of health supplement products to meet the clinical nutrition needs of patients
Slide 23: We Market Our Brands In
WE MARKET OUR BRANDS IN Bangladesh Hong Kong Oman Myanmar Philippines Cambodia Vietnam Malaysia Brunei Singapore Indonesia
Slide 24: Medical Hypermart and Digital
MEDICAL HYPERMART AND DIGITAL What We Do 1. Wholesaler of pharmaceutical products and medical supplies. 2. Cater largely to private clinics and pharmacies. 3. > 3,000 customers and > 4,000 items in our inventory. 4. Have B2B e-commerce platform that facilitates 24/7 ordering. 5. Only in Singapore at
Slide 25: Medical Hypermart and Digital
MEDICAL HYPERMART AND DIGITAL 1st pharmaceutical wholesaler in Singapore to establish an online platform and capture Over 1,500 new digital opportunities members on Medical Hypermart MORE THAN ! YEARS HERITAGE BRAND
Slide 26: Financial Snapshot as at Dec 2018
FINANCIAL SNAPSHOT AS AT 31 DEC 2018 FY2018 S$7.5m S$22.4m cash inflow from cash and cash REVENUE operating activities equivalent S$120.9m 7.7% Strong Cash Generative Business PROFIT gearing ratio1 Low Gearing Ratio S$5.4m 1 Total Debt / Total Equity (after IPO expense of S$0.9m) 0.55c >30% dividend
Slide 27: Financial Highlights
FINANCIAL HIGHLIGHTS Revenue (S$’m) Profit After Tax (S$’m) 6.1 112.7 120.9 101 5.1 5.2 5.4 78.3 FY2015 FY2016 FY2017 FY2018 FY2015 FY2016 FY2017 FY2018
Slide 28: Revenue Segment Breakdown by Business & Geography
REVENUE SEGMENT BREAKDOWN BY BUSINESS & GEOGRAPHY FY18 Revenue Breakdown by FY18 Revenue Breakdown by Business (S$’m) Geography (S$’m) Medical Hypermart & Digital Others 6.7 (5.5%) 38.4 7.7 (6.4%) (31.7%) 53.9 69.4 (44.5%) (57.4%) 52.7 13.2 (43.6%) (10.9%) Proprietary Specialty Pharma Brands Princip
Slide 29: Future Growth
FUTURE GROWTH • New product launches - Products with patented and patent pending technologies to grow the skin health business - Continue to enhance product offerings through licencing and research collaborations - Launching new specialty pharma products in regional markets • Establishing a broader
Slide 30: Hyphens Pharma International Limited (SGX: 1J5)
Hyphens Pharma International Limited (SGX: 1J5) 16 Tai Seng Street, Level 4, Singapore 534138 www.hyphens.com.sg
Hyphens Pharma International — Shareholder Meeting (April 2019) on 6ix